Biomea Fusion, Inc. Employee Count
The employee counts Biomea Fusion, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 106; Filing 2025-03-31; Lease expense per employee $47,056.60.
- 2023-12-31: Employees (as filed) 103; Filing 2024-03-28; Lease expense per employee $52,669.90.
- Available history
- 2023-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 106 full-time | 2025-03-31 | $47,056.60 operating + variable |
| 2023-12-31 | 103 full-time | 2024-03-28 | $52,669.90 operating + variable |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |